- Filed
- Dec 14, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Dec 14, 2020 | 11.01M sh |
| Cash And Equivalents | Q3 2020 · Oct 31, 2020 | $1.7M |
| Cash And Equivalents | Q3 2020 · Feb 1, 2020 | $1.97M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $2.64M |
| Current Liabilities | Q3 2020 · Oct 31, 2020 | $15.45M |
| Current Liabilities | Q3 2020 · Feb 1, 2020 | $32.57M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $32.77M |
| Total Liabilities | Q3 2020 · Oct 31, 2020 | $24.68M |
| Total Liabilities | Q3 2020 · Feb 1, 2020 | $38.68M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $37.87M |
| Current Assets | Q3 2020 · Oct 31, 2020 | $10.66M |
| Current Assets | Q3 2020 · Feb 1, 2020 | $14.85M |
| Current Assets | Q3 2020 · Dec 31, 2019 | $16.49M |
| Total Assets | Q3 2020 · Oct 31, 2020 | $23.64M |
| Total Assets | Q3 2020 · Feb 1, 2020 | $27.41M |
| Total Assets | Q3 2020 · Dec 31, 2019 | $27.85M |
| Shares Diluted | Q3 2020 · Feb 1, 2020 | 4.38M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 895K sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 851K sh |
| Operating Cash Flow | Q3 2020 · Feb 1, 2020 | −$580K |
| Operating Cash Flow restated | Q3 2020 · Sep 30, 2019 | −$4.4M |
| Eps Diluted | Q3 2020 · Feb 1, 2020 | −$0.48 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$3.71 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$14.81 |
| Eps Basic | Q3 2020 · Feb 1, 2020 | −$0.48 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$3.71 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$14.81 |
| Sga Expense | Q3 2020 · Feb 1, 2020 | $2.36M |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $2.96M |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $10.46M |
| Net Income | Q3 2020 · Feb 1, 2020 | −$2.12M |
| Net Income | Q3 2020 · Sep 30, 2019 | −$3.32M |
| Net Income | Q3 2020 · Sep 30, 2019 | −$12.6M |
| Net Income | Q3 2020 · Jun 30, 2019 | −$5.61M |
| Net Income | Q3 2020 · Mar 31, 2019 | −$3.66M |
| Operating Income | Q3 2020 · Feb 1, 2020 | −$850K |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$1.88M |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$8.74M |
| Gross Profit | Q3 2020 · Feb 1, 2020 | $1.51M |
| Gross Profit restated | Q3 2020 · Sep 30, 2019 | $1.08M |
| Gross Profit restated | Q3 2020 · Sep 30, 2019 | $1.72M |
| Cost Of Revenue | Q3 2020 · Feb 1, 2020 | $3.78M |
| Cost Of Revenue restated | Q3 2020 · Sep 30, 2019 | $3.07M |
| Cost Of Revenue restated | Q3 2020 · Sep 30, 2019 | $6.88M |
| Revenue | Q3 2020 · Feb 1, 2020 | $5.29M |
| Revenue restated | Q3 2020 · Sep 30, 2019 | $4.14M |
| Revenue restated | Q3 2020 · Sep 30, 2019 | $8.6M |
| Stockholders Equity | Q3 2020 · Dec 31, 2019 | −$10.02M |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | −$11.5M |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | −$8.24M |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | −$5.12M |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | −$2.76M |
| Capex restated | Q3 2020 · Sep 30, 2019 | $14K |